AMO Pharma raises $25 mln

AMO Pharma Ltd. said Wednesday it raised $25 million in private equity financing from Woodford Investment Management. The investment came from the Woodford Patient Capital Trust, which Woodford Investment launched this year. AMO Pharma is a biopharmaceutical company focusing on debilitating diseases with limited or no treatment options.

DealsNorth AmericaUSBriefs